Showing 3 posts of 3 posts found.


Amicus pulls plug on rare skin disease drug after Phase 3 failure

September 14, 2017
Research and Development Amicus, epidermolysis bullosa, pharma, pharmaceutical, trial failure

New Jersey-based biotech firm Amicus Therapeutics has been forced to terminate its development of its candidate for treating rare skin …


Amicus links with Biogen Idec

September 12, 2013
Research and Development, Sales and Marketing Amicus, Biogen IDEC, Parkinson's

Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …

gsk image

GSK raises stake in Amicus for Fabry drug

July 18, 2012
Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D

GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …

Latest content